Eris Lifesciences Limited (ERIS.NS) - Quarterly Income Statement

Home
ERIS.NS
Financials

1389.45 (INR) • At close September 16, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1
Revenue Numbers are in millions	7,197.2	5,509.25	4,834.81	5,005.2	4,600.29	3,965.92	4,178.4	4,553.32	3,920.52	3,011.01	3,280.74	3,533.37	3,436.56	2,742.53	3,050.42	3,252.67	2,880.12	2,440.85	2,617.53	2,804.56	2,718.89	2,110.85	2,484.78	2,605.62	2,507.61	2,121.92	2,089.71	2,492.34	1,852.07	1,591.48	1,844.7	1,989.16	1,824.23
Cost of Revenue Numbers are in millions	3,891.5	2,745.59	888.69	945.97	783.95	727.57	887.82	1,057.2	850.91	640.9	614.4	664	688.66	640.27	564.29	638.29	575.85	443.04	428.18	457.21	458.93	363.21	393.92	405.65	388.66	351.19	336.69	399.76	274.58	304.47	221.04	233.26	309.26
Gross Profit Numbers are in millions	3,305.7	2,763.66	3,946.12	4,059.23	3,816.34	3,238.35	3,290.58	3,496.12	3,069.61	2,370.11	2,666.34	2,869.37	2,747.9	2,102.26	2,486.13	2,614.38	2,304.27	1,997.81	2,189.35	2,347.35	2,259.96	1,747.64	2,090.86	2,199.97	2,118.95	1,770.73	1,753.02	2,092.58	1,577.49	1,287.01	1,623.66	1,755.9	1,514.97
Gross Profit Ratio Numbers are in millions	0.459	0.502	0.816	0.811	0.83	0.817	0.788	0.768	0.783	0.787	0.813	0.812	0.8	0.767	0.815	0.804	0.8	0.818	0.836	0.837	0.831	0.828	0.841	0.844	0.845	0.834	0.839	0.84	0.852	0.809	0.88	0.883	0.83
Reseach & Development Expenses Numbers are in millions	0	0	0	0	0	61	0	0	0	327.38	0	0	0	50.92	0	0	0	41.96	0	0	0	41.12	0	0	0	7.74	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	1,189.54	0	0	0	633.63	0	0	0	582.44	0	0	0	633.57	0	0	0	651.67	0	0	0	496.67	0	0	0	380.77	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	63.85	0	0	0	87.47	0	0	0	125.05	0	0	0	182.38	0	0	0	367.01	0	0	0	373.37	0	0	0	378.27	0	0	0
SG&A Numbers are in millions	1,565.2	1,818.35	1,232.44	1,310.27	1,041.34	1,253.39	1,102.73	1,081.74	786.09	721.1	615.91	629.56	883.72	707.49	596.92	599.99	570.97	815.95	524.29	505.11	471.49	1,018.68	474.52	468.95	490.81	870.04	428.19	372.71	356.5	759.04	314.55	348.96	314.05
Other Expenses Numbers are in millions	16.4	151.48	41.97	34.81	9.89	10.04	22.37	51.74	27.38	-169.94	51.78	69.87	58.65	-60.4	30.72	20.84	13.39	-128	84.66	51.7	28.26	-182.25	102.88	61.53	35.24	-183.61	57.84	64.52	68.67	-197.77	55.38	91.71	51.54
Operating Expenses Numbers are in millions	1,565.2	1,818.35	2,648.19	2,668.73	2,527.83	2,400.71	2,217.54	2,267.84	2,011.99	1,536.55	1,617.92	1,620.74	1,627.79	1,259.85	1,519.88	1,472.34	1,367.95	1,314.91	1,548.52	1,366.21	1,329.93	1,214.27	1,251.54	1,275.9	1,306.19	1,142.98	1,008.97	1,167.69	909.36	869.05	959.74	1,064.05	833.15
Operating Income Numbers are in millions	1,740.5	945.31	1,339.9	1,425.31	1,288.51	847.68	1,095.41	1,280.02	1,057.62	827.88	1,048.42	1,248.63	1,120.11	842.41	966.25	1,142.04	936.32	682.9	640.83	981.14	930.03	533.37	839.32	924.07	812.76	626.64	744.05	924.89	668.13	417.96	663.92	691.85	681.82
Operating Income Ratio Numbers are in millions	0.242	0.172	0.277	0.285	0.28	0.214	0.262	0.281	0.27	0.275	0.32	0.353	0.326	0.307	0.317	0.351	0.325	0.28	0.245	0.35	0.342	0.253	0.338	0.355	0.324	0.295	0.356	0.371	0.361	0.263	0.36	0.348	0.374
Total Other Income Expenses Net Numbers are in millions	-587.3	-178.84	-181.18	-162.95	-163.67	-88.67	-30.02	-70.7	-44.91	25.5	41.37	59.21	50.86	4.87	26.71	16.32	10.05	-67.94	80.77	46.56	19.21	49.03	51.8	-0.96	-35.81	-4.5	30.21	64.35	68.52	-8.02	55.13	83.85	51.21
Income Before Tax Numbers are in millions	1,153.2	766.47	1,158.72	1,262.36	1,124.84	759.01	1,065.39	1,209.32	1,012.71	853.38	1,089.79	1,307.84	1,170.97	847.28	992.96	1,158.36	946.37	614.96	721.6	1,027.7	949.24	582.4	891.12	923.11	776.95	622.14	774.26	989.24	736.65	409.94	719.05	775.7	733.03
Income Before Tax Ratio Numbers are in millions	0.16	0.139	0.24	0.252	0.245	0.191	0.255	0.266	0.258	0.283	0.332	0.37	0.341	0.309	0.326	0.356	0.329	0.252	0.276	0.366	0.349	0.276	0.359	0.354	0.31	0.293	0.371	0.397	0.398	0.258	0.39	0.39	0.402
Income Tax Expense Numbers are in millions	259	-29.86	144.12	39.24	188.35	144.23	63.08	15.56	81.96	53.66	82.14	123.91	104.38	164.81	91.46	81.16	56.19	52.24	86.91	100.59	108.69	43.56	89.14	68.05	61.36	61.36	25.05	57.82	28.28	-8.24	38.29	83.22	105.46
Net Income Numbers are in millions	831.8	709.62	1,027.36	1,234.3	948.6	654.18	1,018.59	1,203.04	945.77	802.96	1,007.65	1,183.93	1,066.59	682.47	901.5	1,077.2	890.18	562.72	634.69	927.11	840.45	540.87	801.38	853.2	712.51	557.87	746.13	928.68	708.37	425.13	681.04	690.22	624.39
Net Income Ratio Numbers are in millions	0.116	0.129	0.212	0.247	0.206	0.165	0.244	0.264	0.241	0.267	0.307	0.335	0.31	0.249	0.296	0.331	0.309	0.231	0.242	0.331	0.309	0.256	0.323	0.327	0.284	0.263	0.357	0.373	0.382	0.267	0.369	0.347	0.342
EPS Numbers are in millions	6.11	5.22	7.55	9.07	6.98	4.81	7.49	8.85	6.96	5.91	7.41	8.71	7.86	5.03	6.65	7.93	6.56	4.14	4.62	6.74	6.11	3.98	5.83	6.2	5.18	4.06	5.43	6.71	5.15	3.13	4.95	5.02	4.56
EPS Diluted Numbers are in millions	6.1	5.21	7.54	9.06	6.98	4.79	7.49	8.84	6.95	5.91	7.41	8.71	7.85	5.03	6.63	7.93	6.55	4.14	4.61	6.73	6.11	3.98	5.83	6.2	5.17	4.06	5.43	6.71	5.15	3.13	4.95	5.02	4.56
EBITDA Numbers are in millions	2,499.9	1,484.32	1,797.06	1,846.25	1,707.34	1,198.98	1,394.38	1,566.2	1,319.43	1,049.59	1,269	1,468.09	1,323.81	967.3	1,103.01	1,268.49	1,054.04	761.68	852.47	1,150.15	1,073.4	738.8	1,038.09	1,068.4	920.75	790.33	868.74	1,042.1	783.04	478.71	780.87	830.49	787.46
EBITDA Ratio Numbers are in millions	0.347	0.269	0.372	0.369	0.371	0.302	0.334	0.344	0.337	0.349	0.387	0.415	0.385	0.353	0.362	0.39	0.366	0.312	0.326	0.41	0.395	0.35	0.418	0.41	0.367	0.372	0.416	0.418	0.423	0.301	0.423	0.418	0.432

Eris Lifesciences Limited

NSE:ERIS.NS Add to watchlist

NSE:ERIS.NS